Vise Technologies Inc. Purchases New Position in Merit Medical Systems, Inc. $MMSI

Vise Technologies Inc. purchased a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the second quarter, HoldingsChannel.com reports. The institutional investor purchased 16,567 shares of the medical instruments supplier’s stock, valued at approximately $1,149,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in MMSI. Los Angeles Capital Management LLC purchased a new stake in Merit Medical Systems during the fourth quarter worth $25,000. Torren Management LLC purchased a new position in Merit Medical Systems during the fourth quarter worth about $38,000. Covestor Ltd lifted its position in Merit Medical Systems by 252.6% during the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 336 shares during the period. Danske Bank A S purchased a new stake in Merit Medical Systems in the 3rd quarter valued at about $42,000. Finally, Quarry LP increased its stake in shares of Merit Medical Systems by 185.9% during the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after acquiring an additional 342 shares during the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analysts Set New Price Targets

MMSI has been the topic of a number of recent analyst reports. Piper Sandler increased their price target on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Needham & Company LLC upped their price objective on Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Wells Fargo & Company increased their target price on Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Robert W. Baird set a $98.00 target price on Merit Medical Systems in a report on Friday, July 31st. Finally, Raymond James Financial reissued an “outperform” rating and set a $100.00 price target on shares of Merit Medical Systems in a research report on Friday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $100.00.

Merit Medical Systems Stock Performance

Merit Medical Systems stock opened at $90.78 on Friday. Merit Medical Systems, Inc. has a 52 week low of $59.74 and a 52 week high of $94.75. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. The stock has a market cap of $5.42 billion, a P/E ratio of 37.51, a price-to-earnings-growth ratio of 2.28 and a beta of 0.49. The stock has a 50 day moving average of $77.41 and a 200-day moving average of $72.57.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The firm had revenue of $418.84 million during the quarter, compared to analyst estimates of $405.25 million. During the same quarter in the prior year, the firm posted $1.01 EPS. Merit Medical Systems’s revenue was up 9.5% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, analysts expect that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.